AmeriPath, Inc. to Present at Banc of America Securities Genomics and Diagnostics Conference.Business Editors/Health & Medical Writers Banc of America Securities Genomics and Diagnostics Conference 2002 RIVIERA BEACH, Fla.--(BUSINESS WIRE)--March 19, 2002 AmeriPath, Inc. (Nasdaq:PATH), one of the nation's leading providers of anatomic pathology services, today announced it will participate in the Banc of America Securities Genomics and Diagnostics Conference 2002 to be held at the The Pierre Hotel in New York City New York City: see New York, city. New York City City (pop., 2000: 8,008,278), southeastern New York, at the mouth of the Hudson River. The largest city in the U.S. , New York New York, state, United States New York, Middle Atlantic state of the United States. It is bordered by Vermont, Massachusetts, Connecticut, and the Atlantic Ocean (E), New Jersey and Pennsylvania (S), Lakes Erie and Ontario and the Canadian province of . The AmeriPath presentation will be made by the Company's Executive Vice President of Genomic Strategies and Chief Medical Officer, Dennis M. Smith, Jr., M.D., on Wednesday, March 20, 2002, at 3:00 p.m. Eastern Time. The public is invited to listen to a webcast of the live presentation via the Internet and an archived replay for two weeks at the following web address: http://www.veracast.com/webcasts/BAS/genomics-2002/id82109323.cfm. The webcast and replay will also be available on the AmeriPath website, http://www.ameripath.com/. AmeriPath is a leading national provider of cancer diagnostics, genomics, and related information services. During 2001, AmeriPath diagnosed approximately 4.0 million tissue biopsies, and interpreted approximately 2.1 million Pap smears. The company's extensive diagnostics infrastructure includes over 400 pathologists and doctorate-level scientists providing services in over 40 independent pathology laboratories, more than 200 hospitals, the Center for Advanced Diagnostics (CAD) and Dermpath Diagnostics, a division of AmeriPath. CAD provides specialized diagnostic testing and information services including Fluorescence In-Situ Hybridization hybridization /hy·brid·iza·tion/ (hi?brid-i-za´shun) 1. crossbreeding; the act or process of producing hybrids. 2. molecular hybridization 3. (FISH), Flow Cytometry, DNA Analysis, Polymerase Chain Reaction polymerase chain reaction (pŏl`ĭmərās') (PCR), laboratory process in which a particular DNA segment from a mixture of DNA chains is rapidly replicated, producing a large, readily analyzed sample of a piece of DNA; the process is (PCR PCR polymerase chain reaction. PCR abbr. polymerase chain reaction Polymerase chain reaction (PCR) ), Molecular Genetics, Cytogenetics cytogenetics /cy·to·ge·net·ics/ (-je-net´iks) the branch of genetics devoted to cellular constituents concerned in heredity, i.e. chromosomes. and HPV HPV human papillomavirus. HPV abbr. human papilloma virus Human papilloma virus (HPV) Typing. AmeriPath has over 60 board-certified dermatopathologists supporting Dermpath Diagnostics, one of the country's leading providers of dermatopathology services in the growing skin diagnostic market. Additionally, AmeriPath provides clinical trial and research development support to firms involved in developing new cancer and genomic diagnostics and therapeutics. Editor's Note: This release is also available at http://www.ameripath.com. |
|
||||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion